CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$98M
(+0.67%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
332
Reduced
303
Closed
69
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$54.5M |
| 2 |
AstraZeneca
AZN
|
$46.3M |
| 3 |
Autodesk
ADSK
|
$40.5M |
| 4 |
Mercado Libre
MELI
|
$39.4M |
| 5 |
Amazon
AMZN
|
$31.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
Alibaba
BABA
|
$60.1M |
| 4 |
Merck
MRK
|
$49.2M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
$48.5M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Archer Daniels Midland
ADM
$30.2B
| $1.64M | 0.01% |
27,293
+1,985
| +8% | +$119K |
|
602
Chegg
CHGG
$185M
| $1.62M | 0.01% |
+23,867
| New | +$1.62M |
|
603
UGI
UGI
$7.43B
| $1.6M | 0.01% |
37,599
| – | – |
|
604
Unilever
UL
$158B
| $1.59M | 0.01% |
29,389
-33,295
| -53% | -$1.81M |
|
605
Vulcan Materials
VMC
$39B
| $1.59M | 0.01% |
9,390
+175
| +2% | +$29.6K |
|
|
B
606
Barrick Mining Corporation
B
$48.5B
| $1.56M | 0.01% |
86,625
+347
| +0.4% | +$6.27K |
|
607
Essex Property Trust
ESS
$17.3B
| $1.55M | 0.01% |
4,842
-360
| -7% | -$115K |
|
608
Carnival Corp
CCL
$42.8B
| $1.53M | 0.01% |
61,008
+12,218
| +25% | +$306K |
|
609
Baker Hughes
BKR
$44.9B
| $1.52M | 0.01% |
61,436
+7,174
| +13% | +$177K |
|
610
Healthpeak Properties
DOC
$12.8B
| $1.51M | 0.01% |
45,088
-189,373
| -81% | -$6.34M |
|
611
Uber
UBER
$190B
| $1.51M | 0.01% |
33,657
+4,970
| +17% | +$223K |
|
|
PARA
612
DELISTED
Paramount Global Class B
PARA
| $1.49M | 0.01% |
37,607
+10,507
| +39% | +$415K |
|
613
Protagonist Therapeutics
PTGX
$3.77B
| $1.48M | 0.01% |
83,646
| – | – |
|
614
Everest Group
EG
$14.3B
| $1.48M | 0.01% |
5,891
-505
| -8% | -$127K |
|
615
Omnicom Group
OMC
$15.4B
| $1.47M | 0.01% |
20,338
-3,537
| -15% | -$256K |
|
616
Pinduoduo
PDD
$177B
| $1.46M | 0.01% |
16,149
-322,594
| -95% | -$29.2M |
|
617
Expeditors International
EXPD
$16.4B
| $1.46M | 0.01% |
12,244
-1,041
| -8% | -$124K |
|
618
Canadian Pacific Kansas City
CP
$70.3B
| $1.45M | 0.01% |
22,203
+4,613
| +26% | +$301K |
|
619
Skyworks Solutions
SWKS
$11.2B
| $1.45M | 0.01% |
8,781
| – | – |
|
620
VeriSign
VRSN
$26.2B
| $1.45M | 0.01% |
7,060
| – | – |
|
621
Conagra Brands
CAG
$9.23B
| $1.43M | 0.01% |
42,336
+3,449
| +9% | +$117K |
|
622
Brown-Forman Class B
BF.B
$13.7B
| $1.43M | 0.01% |
21,335
-1,697
| -7% | -$114K |
|
623
Realty Income
O
$54.2B
| $1.42M | 0.01% |
22,602
-2,335
| -9% | -$147K |
|
624
JD.com
JD
$44.6B
| $1.42M | 0.01% |
19,635
-401,024
| -95% | -$29M |
|
625
Snap-on
SNA
$17.1B
| $1.42M | 0.01% |
6,786
+537
| +9% | +$112K |
|